ChemicalBook > CAS DataBase List > EPOETIN ALFA

EPOETIN ALFA

Product Name
EPOETIN ALFA
CAS No.
113427-24-0
Chemical Name
EPOETIN ALFA
Synonyms
Rhepo;Drg-0062;Abseamed;EPOETIN ALFA;alphaEpoetin;Epoetina alfa;Epoetin alpha;alpha-Epoetin;Epoetine alfa;EPO(ERYTHROPOIETIN)
CBNumber
CB41011881
Molecular Formula
C42H73NO16
Formula Weight
848.03
MOL File
113427-24-0.mol
More
Less

Safety

HS Code 
2937190000
Hazardous Substances Data
113427-24-0(Hazardous Substances Data)
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

EPOETIN ALFA Chemical Properties,Usage,Production

Uses

Anti-anemic; hematinic.

brand name

Epogen (Amgen); Procrit (Ortho Biotech).

General Description

Epoetin alfa, rEPO (Epogen, Procrit), isthe recombinant human erythropoietin produced in Chinesehamster ovary cells into which the human erythropoietin genehas been inserted. These mammalian cells glycosylate theprotein in a manner similar to that observed in human cells.
Epoetin alfa is indicated in anemic patients with chronicrenal failure, including both those who require regular dialysisand those who do not. Epoetin alfa is also indicated inanemia associated with AIDS, treatment of AIDS with zidovudine,frequent blood donations, and neoplastic diseases.It is indicated to prevent anemia in patients who donateblood prior to surgery for future autologoustransfusions and to reduce the need for repeated maintenancetransfusions. The hormone is available as an isotonicbuffered solution, which is administered by the intravenousroute. The solution should not be frozen or shakenand is stored at 36°F to 46°F.

Clinical Use

Epoetin Alfa, recombinant Erythropoietin alfa, Epogen,Procrit, is a glycoprotein that stimulates red blood cellproduction. It is produced in the kidney, and it activates theproliferation and differentiation of specially committed erythroidprogenitors in the bone marrow.
Epoetin is indicated to treat anemia of chronic renal failurepatients, anemia in zidovudine-treated HIV-infectedpatients, and in cancer patients taking chemotherapy. Theresults in these cases have been dramatic; most patients respondwith a clinically significant increase in hematocrit.

Veterinary Drugs and Treatments

EPO has been used to treat dogs and cats for anemia associated with chronic renal failure. Some clinicians state that because of the expense and potential risks associated with its use, PCV’s should be in the “teens” before considering beginning EPO therapy. Development of antibodies to EPO has severely limited its clinical usefulness in veterinary medicine for chronic use. EPO may be demonstrated in the future to have significant benefits in reducing the number or volume of transfusions, or as a neuroprotective agent.

Drug interactions

Potentially hazardous interactions with other drugs Hyperkalaemia with ACE inhibitors and angiotensin-II antagonists

Metabolism

The metabolic fate of both endogenous and recombinant erythropoietin is poorly understood. Current evidence from studies in animals suggests that hepatic metabolism contributes only minimally to elimination of the intact hormone, but desialylated epoetin (i.e. terminal sialic acid groups removed) appears to undergo substantial hepatic clearance via metabolic pathways and/or binding. Desialylation and/or removal of the oligosaccharide side chains of erythropoietin appear to occur principally in the liver; bone marrow also may have a role in catabolism of the hormone. Elimination of desialylated drug by the kidneys, bone marrow, and spleen also may occur; results of animal studies suggest that proximal renal tubular secretion may be involved in renal elimination.

EPOETIN ALFA Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

EPOETIN ALFA Suppliers

Beijing HuaMeiHuLiBiological Chemical
Tel
010-56205725
Fax
010-65763397
Email
waley188@sohu.com
Country
China
ProdList
12335
Advantage
58
AFINE CHEMICALS LIMITED
Tel
+86-0571-85134551
Fax
008657185134895
Email
sales@afinechem.com
Country
China
ProdList
15353
Advantage
58
Chemwill Asia Co.,Ltd.
Tel
86-21-51086038
Fax
86-21-51861608
Email
chemwill_asia@126.com
Country
CHINA
ProdList
23912
Advantage
58
Energy Chemical
Tel
021-58432009 400-005-6266
Fax
021-58436166
Email
marketing1@energy-chemical.com
Country
China
ProdList
44808
Advantage
58
Shaanxi DIDU pharmaceutical and Chemical Co., Ltd
Tel
17691182729 18161915376
Email
1046@dideu.com
Country
China
ProdList
10007
Advantage
58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd
Tel
18162595016; 18162595016
Email
3287908757@qq.com
Country
China
ProdList
9122
Advantage
58
Henan Tianfu Chemical Co.,Ltd.
Tel
+86-0371-55170693 +86-19937530512
Fax
0371-55170693
Email
info@tianfuchem.com
Country
China
ProdList
21634
Advantage
55
Shaanxi LonierHerb Bio Technology Co Ltd
Tel
+86-86-+86-86-029-87551862 +8617702909819
Email
sales006@ingredients-lonier.com
Country
China
ProdList
2633
Advantage
58
United States Biological
Tel
--
Fax
--
Email
sales@advtechind.com
Country
United States
ProdList
6075
Advantage
58

113427-24-0, EPOETIN ALFARelated Search:


  • EPO(ERYTHROPOIETIN)
  • EPOETIN ALFA
  • Rhepo
  • alphaEpoetin
  • alpha-Epoetin
  • Abseamed
  • Drg-0062
  • Epoetin alpha
  • Epoetina alfa
  • Epoetina alfa [inn-spanish]
  • Epoetin-alpha (genetical recombination)
  • Epoetine alfa
  • Erythropoietin for Bioassays United States Pharmacopeia (USP) Reference Standard
  • Recombinant human erythropoletion injection
  • 113427-24-0